 Christoph Kaiser |  John Cleland |
BASKET Study Shows Bare Metal Stents Can Be Better
REFERENCE: 4825 “Clinical Trial Update I” Session
Christoph Kaiser, University of Basel
Bare metal stents may be just as effective, and in some lesions even more effective, than drug eluting stents, according to the findings of the BASKET trial from the University of Basel in which patients receiving drug eluting stents were compared with others having bare metal stents. Christoph Kaiser told a “Clinical Trial Update” session in Barcelona, that it is important to define sub-groups of patients who will do better on bare metal stents rather than simply giving drug eluting stents to all. He discussed the study with Peter Goodwin.
Perindopril Benefits Older Patients with Diastolic Heart Failure
REFERENCE: Abstract 984
John Cleland, University of Hull
A new way of relieving symptoms and reducing morbidity in older patients with diastolic heart failure was announced at the cardiology congress in Barcelona. John Cleland from Hull University in the UK presented his results on the PEP-CHF (Perindopril in Elderly People with Chronic Heart Failure) study looking at the use of the ACE-inhibitor perindopril in comparison with placebo. He explained to Sarah Maxwell that although the investigators found an unexpectedly low rate of mortality and morbidity in both arms of the study, the ACE inhibitor brought worthwhile benefits.
